Product Images Sumatriptan Succinate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Sumatriptan Succinate NDC 71205-274 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemical-structure - chemical structure
71205-274-09 - sumatriptan carton 100mg
Sumatrptan Succinate 100mg tablets are a prescription medication for people suffering from migraine headaches. The tablets are triangular-shaped and pink with "S" on one side and "100" on the other. The medication is manufactured in Halol-389 350, Gujarat, India by Sun Pharmaceutical Industries Ltd. Proficent Rx LP has relabeled this drug and their offices are located in Thousand Oaks, CA 91320. It is important to keep this medication out of reach of children and to store it at a temperature between 20°-25°C (68°-77°F). No available information on how many tablets are in the box.*
Sumatriptan-figure-1 - sumatriptan figure 1
The given text is a figure that displays the estimated probability of achieving headache relief within four hours of treatment with oral sumatriptan. The chart shows different dosages of the sumatriptan and the time to achieve relief. The data is based on three clinical trials providing evidence of effectiveness. Patients not achieving a response within 240 minutes were censored.*
Sumatriptan-figure-2 - sumatriptan figure 2
This is a figure and table showing the estimated probability of patients taking a second dose of Sumatriptan Succinate Tablets or other medication to treat migraine over 24 hours, based on data obtained in 3 clinical controlled trials. The Kaplan-Meier plot shows that patients had a higher probability of taking a second dose within the first 2 hours after the initial dose, and the likelihood decreased over time. Patients who had no response to the initial dose are also included in the plot. No remedication was allowed within 2 hours postdose.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.